Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Alternative Medicine Times.
Press releases published on May 18, 2025

BRISBANE BASED IAN LAZAR DIGITAL LIFESTYLE MAGAZINE COMMENCE FEATURES ON CAR PARK SAFETY SOLUTIONS
Interest in car park safety has grown significantly recently and Ian Lazar Digital confirm they are commencing features on these matters for readers BRISBANE, QUEENSLAND, AUSTRALIA, May 19, 2025 /EINPresswire.com/ -- The Ian Lazar Digital Lifestyle …

Medicines for Poland: L'Europa si trova di fronte a una scelta cruciale sulla riforma del mercato e dei farmaci
VARSAVIA, Polonia, May 19, 2025 (GLOBE NEWSWIRE) -- Il dibattito tra gli Stati membri in merito alla riforma farmaceutica dell'UE per garantire farmaci a prezzi accessibili e sostenere la produzione europea è quasi giunto al termine. La strategia punta a …

Sennza Media Answer Reader Interest To Commence Features On The Usefulness Of Listing On Directory Sites
Australian lifestyle web news portal Sennza Media commence publishing a series of features on the benefits of listing on local and international directory sites SYDNEY, NSW, AUSTRALIA, May 18, 2025 /EINPresswire.com/ -- Sennza Media is an online …

Cytokinetics Presents Additional Data Related to Aficamten at the European Society of Cardiology Heart Failure 2025 Congress
Two New Analyses from SEQUOIA-HCM on Effect of Aficamten Between Patients with Mild and Moderate-to-Severe Symptoms, and Across Geographic Regions HEOR Analyses of Real-World Data Reveal Disparities in Outcomes In Females and Older Patients with Non- …

Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting
Slowing of progression of disease observed via MRI at 24 months Improvements in outcomes and reduction in sorbitol maintained through 24 months Statistically significant correlation between absolute reduction in sorbitol and change in 10MWRT and CMT-FOM …

Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at Peripheral Nerve Society Annual Meeting
Deep, durable and consistent reductions in TTR were sustained at two years, following a one-time dose of nex-z Clinically meaningful improvements in ATTRv-PN related outcomes observed at 24 months compared to baseline, including in patients who were …

Best Anti-Snoring Device 2025: AirSnore Mouthpiece & Drops Review for Sleep Apnea & Deprivation Relief
Glasgow, May 18, 2025 (GLOBE NEWSWIRE) -- Introduction Consistent, uninterrupted sleep is critical to maintaining sharp focus, stable mood, and long-term health. Yet millions of adults struggle with nightly snoring or mild obstructive sleep apnea — often …